The Alveolar Rhabdomyosarcoma Treatment Market is steadily expanding as advances in oncology research, precision medicine, and targeted therapies improve treatment options for patients diagnosed with this rare and aggressive soft tissue cancer. Alveolar rhabdomyosarcoma primarily affects children, adolescents, and young adults, creating a strong demand for effective therapies that enhance...